Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase IIb Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN)
Sponsored by Vera Therapeutics Inc
Active
$140.4K Funding
1 People
External
Related Topics
clinical trials,
nephrology,
immunology,
drug safety,
pharmacology
People
Amy Sussman
Principal Investigator (PI)
Medicine
﹒Professor
